Langeveld M - Search Results

1

Langeveld M, de Vries JH. Langeveld M, et al. Ned Tijdschr Geneeskd. 2013;157(29):A6017. Ned Tijdschr Geneeskd. 2013. PMID: 23859104 Review. Dutch.

2

The long-term effect of energy restricted diets for treating obesity.

Langeveld M, DeVries JH. Langeveld M, et al. Obesity (Silver Spring). 2015 Aug;23(8):1529-38. doi: 10.1002/oby.21146. Epub 2015 Jul 14. Obesity (Silver Spring). 2015. PMID: 26179364 Free article. Review.

3

Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.

Langeveld M, van den Berg SA, Bijl N, Bijland S, van Roomen CP, Houben-Weerts JH, Ottenhoff R, Houten SM, van Dijk KW, Romijn JA, Groen AK, Aerts JM, Voshol PJ. Langeveld M, et al. Metabolism. 2012 Jan;61(1):99-107. doi: 10.1016/j.metabol.2011.05.013. Epub 2011 Aug 3. Metabolism. 2012. PMID: 21816446

4

Glycosphingolipids and insulin resistance.

Aerts JM, Boot RG, van Eijk M, Groener J, Bijl N, Lombardo E, Bietrix FM, Dekker N, Groen AK, Ottenhoff R, van Roomen C, Aten J, Serlie M, Langeveld M, Wennekes T, Overkleeft HS. Aerts JM, et al. Among authors: langeveld m. Adv Exp Med Biol. 2011;721:99-119. doi: 10.1007/978-1-4614-0650-1_7. Adv Exp Med Biol. 2011. PMID: 21910085 Review.

5

CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.

Boot RG, Verhoek M, Langeveld M, Renkema GH, Hollak CE, Weening JJ, Donker-Koopman WE, Groener JE, Aerts JM. Boot RG, et al. Among authors: langeveld m. J Inherit Metab Dis. 2006 Aug;29(4):564-71. doi: 10.1007/s10545-006-0318-8. Epub 2006 May 30. J Inherit Metab Dis. 2006. PMID: 16736095

6

Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia.

Langeveld M, Scheij S, Dubbelhuis P, Hollak CE, Sauerwein HP, Simons P, Aerts JM. Langeveld M, et al. Metabolism. 2007 Mar;56(3):314-9. doi: 10.1016/j.metabol.2006.10.014. Metabolism. 2007. PMID: 17292718

7

Hypermetabolism in Gaucher disease type I is not associated with altered thyroid hormone levels.

Langeveld M, Endert E, Wiersinga WM, Aerts JM, Hollak CE. Langeveld M, et al. J Inherit Metab Dis. 2007 Nov;30(6):985. doi: 10.1007/s10545-007-0715-7. Epub 2007 Oct 5. J Inherit Metab Dis. 2007. PMID: 17912612

8

Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance.

Langeveld M, Ghauharali KJ, Sauerwein HP, Ackermans MT, Groener JE, Hollak CE, Aerts JM, Serlie MJ. Langeveld M, et al. J Clin Endocrinol Metab. 2008 Mar;93(3):845-51. doi: 10.1210/jc.2007-1702. Epub 2007 Dec 18. J Clin Endocrinol Metab. 2008. PMID: 18089699

9

Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease.

Ghauharali-van der Vlugt K, Langeveld M, Poppema A, Kuiper S, Hollak CE, Aerts JM, Groener JE. Ghauharali-van der Vlugt K, et al. Among authors: langeveld m. Clin Chim Acta. 2008 Mar;389(1-2):109-13. doi: 10.1016/j.cca.2007.12.001. Epub 2007 Dec 7. Clin Chim Acta. 2008. PMID: 18164265

10

Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.

de Fost M, Langeveld M, Franssen R, Hutten BA, Groener JE, de Groot E, Mannens MM, Bikker H, Aerts JM, Kastelein JJ, Hollak CE. de Fost M, et al. Among authors: langeveld m. Atherosclerosis. 2009 May;204(1):267-72. doi: 10.1016/j.atherosclerosis.2008.08.027. Epub 2008 Sep 2. Atherosclerosis. 2009. PMID: 18842264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page